Additionally, tumor cells can upregulate the expression of checkpoint molecules, such as programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), which can inhibit T cell activation and promote immune evasion [57]. Here, CTLA4 is linked to neoplasm.